Milestone Scientific Inc. Receives NYSE American Notice for Non-Compliance with Listing Standards

Reuters
Oct 14, 2025
<a href="https://laohu8.com/S/MLSS">Milestone Scientific</a> Inc. Receives NYSE American Notice for Non-Compliance with Listing Standards

Milestone Scientific Inc. announced that it has received a notice from the NYSE American stating the company is not in compliance with certain continued listing standards. The company must submit a plan of compliance by November 7, 2025, outlining steps to regain compliance. If the plan is accepted, Milestone Scientific will remain listed but will undergo periodic reviews. Failure to submit an acceptable plan or achieve compliance by April 8, 2027, could result in delisting from the exchange. The company's management is currently working on addressing the deficiency and intends to meet the required deadline.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Milestone Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-017919), on October 14, 2025, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10